Opinion

Video

DeFi: Nirogacestat in Patients with Progressing Desmoid Tumors

Jonathan Trent, MD, PhD, discusses the rationale and design of the DeFi study, instrumental in the FDA approval of nirogacestat, and explores key efficacy and safety findings from this research.

Video Player is loading.
Current Time 0:00
Duration 4:43
Loaded: 0%
Stream Type LIVE
Remaining Time 4:43
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected